WST

West Pharmaceutical Services

Healthcare Medical Instruments & Supplies NYSE

About the company

West Pharmaceutical Services, headquartered in Exton, Pennsylvania, has solidified its position as a leading provider of medical supplies in the healthcare industry. With a robust portfolio of elastomer-based products, West serves as a crucial supplier to numerous pharmaceutical, biotechnology, and generic drug companies. At the heart of West's operations is its commitment to the development, manufacture, and distribution of high-quality supplies for the containment and administration of injectable drugs. From essential elements like syringes, stoppers, and plungers to more advanced devices such as auto-injectors and other self-injection platforms, West plays a vital role in ensuring the safe and effective delivery of medications. The company's business is divided into two key segments: proprietary products and contract-manufactured products. Proprietary products hold the lion's share, accounting for 82% of West's sales in 2021. These products are developed and marketed by West under its own brand, leveraging the company's expertise and experience to meet the specific needs of the healthcare industry. On the other hand, contract-manufactured products make up the remaining 18% of West's sales. In this segment, West collaborates with its clients to develop and produce customized medical supplies tailored to their unique requirements. This partnership approach allows West to leverage its extensive manufacturing capabilities and technical expertise, catering to the diverse needs of its customers. While West is proud to contribute to the healthcare sector in the United States, the company's reach extends far beyond its home country. Approximately 55% of West's revenue is generated from international markets, highlighting its global presence and success in meeting the demands of a diverse range of customers worldwide. The remaining 45% of revenue comes from within the United States, where West continues to play an integral role in supporting healthcare providers and patients. In an ever-evolving healthcare landscape, West Pharmaceutical Services remains committed to driving innovation and excellence in the field of medical supplies. By providing top-notch elastomer-based products and partnering with pharmaceutical companies, West ensures the safe and efficient delivery of injectable drugs while maintaining its position as a trusted and reliable industry leader.

Website: https://www.westpharma.com

Data updated: June 2, 2026

Sector comparison

We compare this company with the typical (middle) company in the same industry to show how it looks against similar businesses. This is information, not a recommendation.

Healthcare · 1346 peers in sector

Metric WST Sector median Vs. industry
P/E 42.40 20.10 ↑ Above average
EPS 7.46 USD -1.14 USD ↑ Above average
Dividend yield 0.27% 0.00% ↑ Above average
Profit margin 16.85% 0.00% ↑ Above average
ROE 19.13% -58.84% ↑ Above average

Higher and lower here are only a comparison with the typical company in the industry — a higher or lower value on its own does not mean better or worse.

Financial statements & historical data

Income statements, balance sheets, cash flow, earnings and dividend history are available for registered users

Sign up for free

AI Summary

AI-generated company analysis is available for registered users.

Sign up for free

Where does this data come from?

Frequently Asked Questions

What is West Pharmaceutical Services?
West Pharmaceutical Services, headquartered in Exton, Pennsylvania, has solidified its position as a leading provider of medical supplies in the healthcare industry. With a robust portfolio of elastomer-based products, West serves as a crucial supplier to numerous pharmaceutical, biotechnology, and generic drug companies. At the heart of West's operations is its commitment to the development, manufacture, and distribution of high-quality supplies for the containment and administration of injectable drugs. From essential elements like syringes, stoppers, and plungers to more advanced devices such as auto-injectors and other self-injection platforms, West plays a vital role in ensuring the safe and effective delivery of medications. The company's business is divided into two key segments: proprietary products and contract-manufactured products. Proprietary products hold the lion's share, accounting for 82% of West's sales in 2021. These products are developed and marketed by West under its own brand, leveraging the company's expertise and experience to meet the specific needs of the healthcare industry. On the other hand, contract-manufactured products make up the remaining 18% of West's sales. In this segment, West collaborates with its clients to develop and produce customized medical supplies tailored to their unique requirements. This partnership approach allows West to leverage its extensive manufacturing capabilities and technical expertise, catering to the diverse needs of its customers. While West is proud to contribute to the healthcare sector in the United States, the company's reach extends far beyond its home country. Approximately 55% of West's revenue is generated from international markets, highlighting its global presence and success in meeting the demands of a diverse range of customers worldwide. The remaining 45% of revenue comes from within the United States, where West continues to play an integral role in supporting healthcare providers and patients. In an ever-evolving healthcare landscape, West Pharmaceutical Services remains committed to driving innovation and excellence in the field of medical supplies. By providing top-notch elastomer-based products and partnering with pharmaceutical companies, West ensures the safe and efficient delivery of injectable drugs while maintaining its position as a trusted and reliable industry leader.
Are West Pharmaceutical Services shares expensive?
The price-to-earnings (P/E) ratio of West Pharmaceutical Services is 42.40 — the share price is 42.40 times the annual profit per share. That is higher than the typical company in the same industry (industry median: 20.10). This is information, not a recommendation. (as of 2026-06-02)
How big is West Pharmaceutical Services?
The market capitalization of West Pharmaceutical Services — the combined value of all its shares — is 22.35 B USD. The higher the market cap, the larger the company. (as of 2026-06-02)
Does West Pharmaceutical Services pay dividends?
The dividend yield of West Pharmaceutical Services is 0.27% — it shows the annual dividend relative to the share price. This is information, not a recommendation. (as of 2026-06-02)
What sector does West Pharmaceutical Services belong to?
West Pharmaceutical Services operates in the Healthcare sector, industry: Medical Instruments & Supplies.

What do you gain?

With Ecrumen you gain full control over your investments and assets!

All your assets
Stock market investments, real estate, bonds. Be aware of what you have in your portfolio!
AI at the service of your investments
Analyze and optimize your investments using the latest technologies. Sentiments, analyses, tips, reports. Always with up-to-date data!
A community eager to help
Find a place with people similar to you. Share your opinions, see how others manage their investments. Get help with the problems that bother you!
What do you gain?

Want to stay up to date?

Subscribe to our newsletter to stay up to date with Ecrumena news and market information. No spam, unsubscribe in one click.

For more information, please refer to our terms of use.

0/120